China Approves Advanced Blood Clot Removal Medical Device for Peripheral Vessels
TL;DR
VentiV Scientific gains market advantage in China with NMPA clearance for Control Medical Thrombectomy platform.
Control Medical Technology's 7 - 11F Mechanical Thrombectomy System utilizes large-lumen catheters connected to Aspirator for blood clot removal.
The Control System's innovative design enhances patient outcomes in China by providing clinicians with broader treatment options for various vascular diseases.
Blood clot removal procedures explained: from accessing femoral artery to applying suction, Control System offers flexible catheters for effective treatment.
Found this article helpful?
Share it with your network and spread the knowledge!
VentiV Scientific has secured approval from China's National Medical Products Administration (NMPA) for its Control Medical Technology 7 – 11F Mechanical Thrombectomy platform, marking a significant advancement in blood clot removal technology for peripheral vessels.
The device offers clinicians an advanced solution for managing various vascular conditions, including peripheral arterial disease, acute limb ischemia, and deep vein thrombosis. The platform's unique design provides flexible treatment options with catheters ranging from 7F to 11F outer diameter, enabling improved tracking and access in peripheral vasculature.
Thrombectomy procedures are critical medical interventions that remove blood clots from blood vessels, potentially preventing serious complications such as stroke, heart attack, and limb damage. The new technology addresses the complexity of clot removal by accommodating different clot characteristics, including soft-fresh and hard-aged thrombus.
Through a strategic partnership with Shanghai Easy-Flow MedTech, VentiV Scientific aims to leverage China's large and growing medical device market. The device's clearance represents an opportunity to enhance patient outcomes and provide clinicians with more sophisticated treatment tools.
The Control Medical Technology platform includes large-lumen, flexible catheters with kink-resistant properties, powered by proprietary mechanical aspirators and electromechanical pumps. This technological approach offers increased speed, force, volume, and control during clot removal procedures.
This regulatory approval signals a potential expansion of advanced medical device technologies in the Chinese market, highlighting the ongoing innovation in minimally invasive vascular treatment solutions.
Curated from 24-7 Press Release
